Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin - propensity score matching study.

BMC Pharmacol Toxicol · 2023 · PMC10720047 · PMID 38093310

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, these results did not reach statistical significance when a propensity score analysis was performed, suggesting a weak association between the use of Rivaroxaban and the development of dementia.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.